Plain-English translation of NCT07245667 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing tolnaftate, an antifungal medication, in a new stick applicator form to treat athlete's foot (tinea pedis). Researchers want to see which of three different stick formulas works best and is safest for people with this common fungal infection. The study will help determine if this new delivery method is effective compared to other treatments.
Athlete's foot is a persistent fungal infection that affects many people, and current treatment options don't always work well for everyone. This trial exists to see if the new stick applicator format makes this medication easier to use and more effective than existing options.
You likely qualify if…
You likely don't qualify if…
If accepted, you would apply one of three test formulas (as a stick, like a deodorant stick) to your affected foot area twice each day for four weeks. You'll attend study visits where staff check how well the treatment is working and monitor for any side effects. Throughout the trial, you'll need to avoid using any other antifungal treatments and follow the study protocol carefully.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States